Regenxbio (RGNX) Issues Update on NAV Gene Therapy for MPS I, MPS II
Go back to Regenxbio (RGNX) Issues Update on NAV Gene Therapy for MPS I, MPS II| Jennison Natural Resources Fund Class B (NASDAQ: RGNX) | Delayed: 16.04 +0.14 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.90 | 52 Week High | $25.00 | |||
| Open | $15.96 | 52 Week Low | $7.07 | |||
| Day High | $16.66 | P/E | N/A | |||
| Day Low | $15.60 | EPS | $0.00 | |||
| Volume | 425,390 | |||||
